<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="correction" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2022.8388</article-id>
<article-id pub-id-type="publisher-id">OR-48-04-08388</article-id>
<article-categories>
<subj-group>
<subject>Corrigendum</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Yin</surname><given-names>Binbin</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Zhenping</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yiyun</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xuchu</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Weiwei</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Yu</surname><given-names>Pan</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Duan</surname><given-names>Xiuzhi</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Chunhua</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yuhua</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yurong</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Pan</surname><given-names>Xiaoyan</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Yao</surname><given-names>Hangping</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Liao</surname><given-names>Zhaoping</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Tao</surname><given-names>Zhihua</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection">
<month>10</month>
<year>2022</year></pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>08</month>
<year>2022</year></pub-date>
<volume>48</volume>
<issue>4</issue>
<elocation-id>173</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; Yin et al.</copyright-statement>
<copyright-year>2022</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Rep 37: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="corrected-article" vol="37" page="3209" id="RA1" xlink:href="10.3892/or.2017.5585" ext-link-type="doi">3209&#x2013;3218</related-article>, 2017; DOI: 10.3892/or.2017.5585</p>
<p>Subsequently to the publication of the above article, the authors have discovered that the version of <xref rid="f5-or-48-04-08388" ref-type="fig">Fig. 5</xref> included in the paper was an incorrect version, and that two pairs of data panels were inadvertently included in <xref rid="f6-or-48-04-08388" ref-type="fig">Fig. 6D</xref> (the data panels for the NC&#x002B;migration and NC&#x002B;HGF&#x002B;U0126&#x002B;invasion experiments for the PC3 cells, and the data panels for the NC&#x002B;invasion and NC&#x002B;HGF&#x002B;U0126&#x002B;invasion experiments for the DU145 cells) that contained overlapping data derived from the same source. These data were intended to represent the results obtained under different experimental conditions. Furthermore, the GAPDH control bands in <xref rid="f4-or-48-04-08388" ref-type="fig">Fig. 4A</xref> (DU145 cells) and the p-ERK1/2 bands in <xref rid="f6-or-48-04-08388" ref-type="fig">Fig. 6A</xref> (PC3 cells) were incorrectly chosen for these figures. After having consulted the original data, the authors discovered that unintended errors were made in assembling the data for these graphs. In uploading the corrected version of <xref rid="f5-or-48-04-08388" ref-type="fig">Fig. 5</xref>, <xref rid="f3-or-48-04-08388" ref-type="fig">Fig. 3C and D</xref> and <xref rid="f4-or-48-04-08388" ref-type="fig">Fig. 4C and D</xref> were adjusted accordingly.</p>
<p>The corrected versions of <xref rid="f3-or-48-04-08388" ref-type="fig">Figs. 3</xref>, <xref rid="f4-or-48-04-08388" ref-type="fig">4</xref>, <xref rid="f5-or-48-04-08388" ref-type="fig">5</xref>, and <xref rid="f6-or-48-04-08388" ref-type="fig">6</xref> are shown on the subsequent pages. The authors regret the errors that were made during the preparation of the published figures, and confirm that these errors did not affect the conclusions reported in the study. The authors are grateful to the Editor of <italic>Oncology Reports</italic> for allowing them the opportunity to publish a Corrigendum, and all the authors agree to this Corrigendum. Furthermore, they apologize to the readership for any inconvenience caused.</p>
</body>
<floats-group>
<fig id="f3-or-48-04-08388" position="float">
<label>Figure 3.</label>
<caption><p>Functional role of RON in the migration and invasion of PCa cell lines. (A) Detection of siRNA-mediated knockdown of RON in PC3 and DU145 cells by western blotting and real-time PCR. (B) The expression of RON, E-cadherin and N-cadherin was determined by western blotting after RON knockdown and MSP (100 ng/ml) stimulation in PC3 and DU145 cells. (C and D) Transwell assays for the effects of RON silencing and MSP (100 ng/ml) on the migratory and invasive potentials of PC3 and DU145 cells. &#x002A;P&#x003C;0.05, &#x002A;&#x002A;P&#x003C;0.01, &#x002A;&#x002A;&#x002A;P&#x003C;0.001; NS, not significant.</p></caption>
<graphic xlink:href="or-48-04-08388-g00.jpg"/>
</fig>
<fig id="f4-or-48-04-08388" position="float">
<label>Figure 4.</label>
<caption><p>Functional role of c-Met in the metastasis and invasion of PCa cell lines. (A) Detection of the siRNA-mediated knockdown of c-Met in PC3 and DU145 cells by real-time PCR and western blotting. (B) The expression of c-Met, E-cadherin and N-cadherin was determined by western blotting after c-Met knockdown and HGF (50 ng/ml) stimulation in the PC3 and DU145 cells. (C and D) Transwell assays of the effects of c-Met silencing and HGF (50 ng/ml) on the migratory and invasive potentials of the PC3 and DU145 cells. (E) Morphological changes of PC3 and DU145 cells stimulated by HGF (50 ng/ml) and foretinib. (F and G) HGF (50 ng/ml) induced cell scattering in the PC3 and DU145 cells. &#x002A;P&#x003C;0.05, &#x002A;&#x002A;P&#x003C;0.01, &#x002A;&#x002A;&#x002A;P&#x003C;0.001; NS, not significant.</p></caption>
<graphic xlink:href="or-48-04-08388-g01.jpg"/>
</fig>
<fig id="f5-or-48-04-08388" position="float">
<label>Figure 5.</label>
<caption><p>Functional role of RON and c-Met in the metastasis and invasion of PC a cell lines. (A) Transwell assays for the effects of si-RON and MSP (100 ng/ml) on migratory and invasive potentials of PC3 and DU145 cells (magnification, &#x00D7;200). (B) Transwell assays for the effects of si-c-Met and HGF (50 ng/ml) on the migratory and invasive potentials of PC3 and DU145 cells (magnification, &#x00D7;200).</p></caption>
<graphic xlink:href="or-48-04-08388-g02.jpg"/>
</fig>
<fig id="f6-or-48-04-08388" position="float">
<label>Figure 6.</label>
<caption><p>RON and c-Met mediates PCa metastasis via the ERK1/2 pathway. (A) Effect of RON and c-Met on phosphorylation of p-ERK1/2 was analyzed by western blotting. (B) PC3 and DU145 cells were treated with MSP or HGF for 24 h. Level of p-ERK1/2 was detected by western blotting. (C and D) Migration and invasion assays were carried out in the PC3 and DU145 cells following treatment with MSP, HGF and U0126 for 24 h (magnification, &#x00D7;200). Each experiment was performed in triplicate. &#x002A;&#x002A;P&#x003C;0.01, &#x002A;&#x002A;&#x002A;P&#x003C;0.001.</p></caption>
<graphic xlink:href="or-48-04-08388-g03.jpg"/>
</fig>
</floats-group>
</article>
